EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

FDA’s proposed rule and its regulatory impact on emerging and reemerging neglected tropical diseases in the United States

Alberto E Paniz-Mondolfi iD, Juan David Ramírez iD

PLOS Neglected Tropical Diseases · 2024

DOI: 10.1371/journal.pntd.0012116 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift PLOS Neglected Tropical Diseases, 2024. Verfasst von Alberto E Paniz-Mondolfi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Microbiology Laboratory, Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New…. Hauptthemen laut MEDLINE: Neglected Diseases, United States Food and Drug Administration, Communicable Diseases, Emerging. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diagnosing infectious diseases significantly influences patient care, aiding in outbreak identification, response, and public health monitoring. However, the range of FDA-approved molecular tests remains notably limited, especially concerning neglected tropical diseases (NTDs). Drawing upon our experience as one of the largest healthcare networks in the greater New York metropolitan area, this viewpoint manuscript aims to spotlight the existing diagnostic landscape and unmet clinical needs for 4 emerging NTDs increasingly prevalent in the United States, additionally, it delves into the possible adverse effects of the FDA’s Proposed Rule on Laboratory-Developed Tests for these clinical conditions and the broader spectrum of NTDs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neglected DiseasesUnited States Food and Drug AdministrationCommunicable Diseases, EmergingUnited StatesHumansTropical Medicine

Autor:innen und Institutionen

  • Molecular Microbiology Laboratory, Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.

ORCID-Profile: Alberto E Paniz-Mondolfi, Juan David Ramírez

Zitieren

APA

Paniz-Mondolfi, A. E., & Ramírez, J. D. (2024). FDA’s proposed rule and its regulatory impact on emerging and reemerging neglected tropical diseases in the United States. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0012116

Vancouver

Paniz-Mondolfi AE, Ramírez JD. FDA’s proposed rule and its regulatory impact on emerging and reemerging neglected tropical diseases in the United States. PLOS Neglected Tropical Diseases. 2024. doi:10.1371/journal.pntd.0012116

BibTeX
@article{PanizMondolfi2024,
  author = {Paniz-Mondolfi, Alberto E and Ramírez, Juan David},
  title = {FDA’s proposed rule and its regulatory impact on emerging and reemerging neglected tropical diseases in the United States},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2024},
  doi = {10.1371/journal.pntd.0012116}
}
Kostenlos starten →